New Zealand markets closed

Eargo, Inc. (EAR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.2800+0.2200 (+20.75%)
At close: 04:00PM EDT
1.2800 0.00 (0.00%)
Pre-market: 08:24AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.0600
Open1.0800
Bid1.2800 x 1300
Ask1.2700 x 1000
Day's range1.0700 - 1.5400
52-week range1.0300 - 40.2100
Volume4,156,678
Avg. volume820,855
Market cap50.379M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-4.4630
Earnings date10 Aug 2022 - 15 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Eargo Announces Receipt of Nasdaq Non-Compliance Letter

    SAN JOSE, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (the “Company” or “Eargo”), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced the Company received a letter (the “Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that because it remains delinquent in filing its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021 and its Annual Report on Form 10-K for th

  • GlobeNewswire

    Eargo Provides Business Update

    Reached settlement agreement to resolve DOJ investigation Company to Hold Conference Call and Web Cast on May 2, 2022 at 8 a.m. Eastern Time SAN JOSE, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (the “Company”), a medical device company on a mission to improve the quality of life of people with hearing loss, today provided a business update and provided guidance on its operating cash runway. Business Updates: Preliminary first quarter 2022 Gross systems shipped is expect

  • GlobeNewswire

    Eargo Finalizes Agreement with the United States to Resolve Investigation With No Admission of Liability

    SAN JOSE, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (“Eargo” or the “Company”) has entered into a civil settlement agreement with the United States to resolve the previously disclosed investigation by the U.S. Department of Justice (the “DOJ”) related to insurance reimbursement claims submitted to various federal employee health plans under the Federal Employee Health Benefits (“FEHB”) program. Eargo fully cooperated with the DOJ’s investigation, the resolution of whic